Literature DB >> 22403144

[Natural course of septo-optic dysplasia: retrospective analysis of 20 cases].

Miguelina León-Gonzalez1, Juan J García-Peñas, Diego Puertas-Bordallo, Miguel A López-Pino, Jesús Argente-Oliver, Verónica Cantarín-Extremera.   

Abstract

INTRODUCTION: Septo-optic dysplasia (SOD) is the variable combination of signs of dysgenesis of the midline of the brain, hypoplasia of the optic nerves and hypothalamus-pituitary dysfunction, which is sometimes associated with a varied spectrum of malformations of the cerebral cortex. AIMS: To describe the natural history and neuroimaging findings in a series of 20 diagnosed patients. PATIENTS AND METHODS: We review the epidemiological, clinical and neuroimaging characteristics of 20 consecutive patients diagnosed with SOD between January 1985 and January 2010. Data obtained from computerised tomography, magnetic resonance imaging of the head, electroencephalogram, visual evoked potentials, ophthalmological evaluation, karyotyping and endocrinological studies were analysed. In seven patients, a study of the gene Homeobox HESX1 was conducted.
RESULTS: Pathological antecedents in the first three months of gestation were presented by 60% of the cases, with normal results in the foetal ultrasound scans. Clinically, the most striking features were visual manifestations (85%), endocrine disorders (50%), mental retardation (60%) and epileptic seizures (55%). Fifty-five per cent were associated to abnormal neuronal migration. In 45%, SOD was the only finding in the neuroimaging scans. Karyotyping was performed in all cases, the results being normal. Gene HESX1 was positive in two of the seven cases studied (both with isolated SOD). None of those with mutation in gene HESX1 presented familial consanguinity. No gene study was conducted with the parents.
CONCLUSIONS: SOD must be classified as a heterogeneous malformation syndrome, which is associated to multiple brain, ocular, endocrine and systemic anomalies. The most severe forms are associated with abnormal neuronal migration and cortical organisation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22403144

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  6 in total

1.  Septo-optic Dysplasia Complex with Omphalocele, Pre-maxillary Agenesis and Encephalocele.

Authors:  Abdul Majeed Kavarodi; Khalid Zharani; El-Sayed Ali; Hussain Sharahili
Journal:  J Maxillofac Oral Surg       Date:  2014-08-03

2.  Septo-optic dysplasia plus diagnosed in adulthood.

Authors:  Adrian Infante-Valenzuela; Carlos R Camara-Lemarroy; Alan L Reyes-Mondragon; Claudio E Muñiz-Landeros; Hector J Villarreal-Velazquez
Journal:  Neurol Sci       Date:  2017-05-04       Impact factor: 3.307

3.  Septo-optic dysplasia: fitting the pieces together.

Authors:  Nélia Ferraria; Sofia Castro; Daniela Amaral; Lurdes Lopes
Journal:  BMJ Case Rep       Date:  2013-05-24

4.  Septo-optic dysplasia in an infant.

Authors:  Ermira Aliu; Juna Musa; Anusha Parisapogu; Erisa Kola; Fjolla Hyseni; Ina Kola; Alejandro Obando Blandón; Pooja Roy; Kampa Prathima; Chandalji Naik Banavath; Pooja Kumbha; Shaik Mashood Tappa; Jasmine Saini; Srikrishnan Pichuthirumalai; Ilir Ahmetgjekaj
Journal:  Radiol Case Rep       Date:  2022-06-26

5.  Acceleration of puberty during growth hormone therapy in a child with septo-optic dysplasia.

Authors:  Gönül Catlı; Ayça Altıncık; Ahmet Anık; Korcan Demir; Handan Güleryüz; Ayhan Abacı; Ece Böber
Journal:  J Clin Res Pediatr Endocrinol       Date:  2014

6.  Six adult patients with septo-optic dysplasia and drug-resistant epilepsy: Clinical findings and course.

Authors:  Mashael AlKhateeb; Richard McLachlan; Jorge Burneo; David Diosy; Seyed Mirsattari
Journal:  Epilepsy Behav Case Rep       Date:  2017-04-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.